Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Planning for retirement at 50? Focus on crucial considerations to secure your financial future and enjoy your golden years.
21,341 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A high-profile insider move has many ALAB investors wondering what comes next. This article breaks down the $60.5 mil...
Investor confidence is up—what’s making headlines? This article breaks down the forces behind a sunnier mood, what it...
NVIDIA has powered the AI rally, and investors are asking if the story can continue. Here's a practical guide on what...
An 8% year rise in a regulated water utility stock and a major investor trimming a $28 million stake highlight how to...
Peloton stock popped today as traders weighed potential index moves and improving momentum. This guide breaks down th...
Broadcom's June earnings could upend market expectations. This deep-dive explains why the report may matter more than...
When one tech giant climbs and another stumbles, the market often stays coldsweat steady. Learn how Micron’s strength...
A rising risk in personal finance is check fraud, where stolen checks are cashed or altered. This guide explains how ...
When Berkshire Hathaway's Greg Abel takes the stage as Buffett’s successor, the market watches not for flashy moves b...
When bitcoin dips under $70k amid a sharp stock sell-off tied to a hawkish FED hold, traders scramble for direction. ...
The Tomi (Tomz) 2026 earnings season offers clues about growth, margins, and strategy. This guide breaks down what to...